1206 related articles for article (PubMed ID: 30060755)
1. Tumor microenvironment participates in metastasis of pancreatic cancer.
Ren B; Cui M; Yang G; Wang H; Feng M; You L; Zhao Y
Mol Cancer; 2018 Jul; 17(1):108. PubMed ID: 30060755
[TBL] [Abstract][Full Text] [Related]
2. GM-CSF Mediates Mesenchymal-Epithelial Cross-talk in Pancreatic Cancer.
Waghray M; Yalamanchili M; Dziubinski M; Zeinali M; Erkkinen M; Yang H; Schradle KA; Urs S; Pasca Di Magliano M; Welling TH; Palmbos PL; Abel EV; Sahai V; Nagrath S; Wang L; Simeone DM
Cancer Discov; 2016 Aug; 6(8):886-99. PubMed ID: 27184426
[TBL] [Abstract][Full Text] [Related]
3. Asporin promotes pancreatic cancer cell invasion and migration by regulating the epithelial-to-mesenchymal transition (EMT) through both autocrine and paracrine mechanisms.
Wang L; Wu H; Wang L; Zhang H; Lu J; Liang Z; Liu T
Cancer Lett; 2017 Jul; 398():24-36. PubMed ID: 28400334
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive cells in tumor immune escape and metastasis.
Liu Y; Cao X
J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
[TBL] [Abstract][Full Text] [Related]
5. CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway.
Zhang L; Wang D; Li Y; Liu Y; Xie X; Wu Y; Zhou Y; Ren J; Zhang J; Zhu H; Su Z
PLoS One; 2016; 11(8):e0158529. PubMed ID: 27505247
[TBL] [Abstract][Full Text] [Related]
6. SIBLINGs and SPARC families: their emerging roles in pancreatic cancer.
Kaleağasıoğlu F; Berger MR
World J Gastroenterol; 2014 Oct; 20(40):14747-59. PubMed ID: 25356037
[TBL] [Abstract][Full Text] [Related]
7. Targeting tumor-associated macrophages to combat pancreatic cancer.
Cui R; Yue W; Lattime EC; Stein MN; Xu Q; Tan XL
Oncotarget; 2016 Aug; 7(31):50735-50754. PubMed ID: 27191744
[TBL] [Abstract][Full Text] [Related]
8. Targeting hypoxic tumor microenvironment in pancreatic cancer.
Tao J; Yang G; Zhou W; Qiu J; Chen G; Luo W; Zhao F; You L; Zheng L; Zhang T; Zhao Y
J Hematol Oncol; 2021 Jan; 14(1):14. PubMed ID: 33436044
[TBL] [Abstract][Full Text] [Related]
9. SNX6 predicts poor prognosis and contributes to the metastasis of pancreatic cancer cells via activating epithelial-mesenchymal transition.
Hu P; Liang Y; Hu Q; Wang H; Cai Z; He J; Cai J; Liu M; Qin Y; Yu X; Jiang C; Zhang B; Wang W
Acta Biochim Biophys Sin (Shanghai); 2018 Nov; 50(11):1075-1084. PubMed ID: 30307473
[TBL] [Abstract][Full Text] [Related]
10. The hepatic pre-metastatic niche in pancreatic ductal adenocarcinoma.
Houg DS; Bijlsma MF
Mol Cancer; 2018 Jun; 17(1):95. PubMed ID: 29903049
[TBL] [Abstract][Full Text] [Related]
11. Expression of annexin II and stromal tenascin C promotes epithelial to mesenchymal transition and correlates with distant metastasis in pancreatic cancer.
Yoneura N; Takano S; Yoshitomi H; Nakata Y; Shimazaki R; Kagawa S; Furukawa K; Takayashiki T; Kuboki S; Miyazaki M; Ohtsuka M
Int J Mol Med; 2018 Aug; 42(2):821-830. PubMed ID: 29749431
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver.
Grünwald B; Harant V; Schaten S; Frühschütz M; Spallek R; Höchst B; Stutzer K; Berchtold S; Erkan M; Prokopchuk O; Martignoni M; Esposito I; Heikenwalder M; Gupta A; Siveke J; Saftig P; Knolle P; Wohlleber D; Krüger A
Gastroenterology; 2016 Nov; 151(5):1011-1024.e7. PubMed ID: 27506299
[TBL] [Abstract][Full Text] [Related]
13. TM4SF1 as a prognostic marker of pancreatic ductal adenocarcinoma is involved in migration and invasion of cancer cells.
Zheng B; Ohuchida K; Cui L; Zhao M; Shindo K; Fujiwara K; Manabe T; Torata N; Moriyama T; Miyasaka Y; Ohtsuka T; Takahata S; Mizumoto K; Oda Y; Tanaka M
Int J Oncol; 2015 Aug; 47(2):490-8. PubMed ID: 26035794
[TBL] [Abstract][Full Text] [Related]
14. Tumor microenvironment and noncoding RNAs as co-drivers of epithelial-mesenchymal transition and cancer metastasis.
Drak Alsibai K; Meseure D
Dev Dyn; 2018 Mar; 247(3):405-431. PubMed ID: 28691356
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk between stromal cells and cancer cells in pancreatic cancer: New insights into stromal biology.
Zhan HX; Zhou B; Cheng YG; Xu JW; Wang L; Zhang GY; Hu SY
Cancer Lett; 2017 Apr; 392():83-93. PubMed ID: 28189533
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia induces immunosuppression, metastasis and drug resistance in pancreatic cancers.
Zhang H; Cao K; Xiang J; Zhang M; Zhu M; Xi Q
Cancer Lett; 2023 Sep; 571():216345. PubMed ID: 37558084
[TBL] [Abstract][Full Text] [Related]
17. Reshaping the Tumor Stroma for Treatment of Pancreatic Cancer.
Vennin C; Murphy KJ; Morton JP; Cox TR; Pajic M; Timpson P
Gastroenterology; 2018 Mar; 154(4):820-838. PubMed ID: 29287624
[TBL] [Abstract][Full Text] [Related]
18. LOX-1 is a poor prognostic indicator and induces epithelial-mesenchymal transition and metastasis in pancreatic cancer patients.
Zhang J; Zhang L; Li C; Yang C; Li L; Song S; Wu H; Liu F; Wang L; Gu J
Cell Oncol (Dordr); 2018 Feb; 41(1):73-84. PubMed ID: 29168159
[TBL] [Abstract][Full Text] [Related]
19. The tumor microenvironment: An irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasis.
Li H; Xu F; Li S; Zhong A; Meng X; Lai M
Cell Adh Migr; 2016 Jul; 10(4):434-46. PubMed ID: 26743180
[TBL] [Abstract][Full Text] [Related]
20. The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer.
Zhou P; Li B; Liu F; Zhang M; Wang Q; Liu Y; Yao Y; Li D
Mol Cancer; 2017 Feb; 16(1):52. PubMed ID: 28245823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
